Abstract:Glioblastoma multiforme (GBM) is a common and highly aggressive primary brain tumor with poor prognosis due in part to drug resistance and high incidence of tumor recurrence. The drug resistant and cancer recurrence phenotype may be ascribed to the presence of cancer stem cells, which seem to reside in special stem-cell niches in vivo and require special culture conditions including certain growth factors and serum-free medium to maintain their stemness in vitro. In this study, we used two lines of stem-like cancer cells (GSC11 and GSC23) derived from the tumor tissues of two GBM patients by classical neurosphere culture system, and showed that addition of serum (FBS) to the medium induced an increase of ROS, leading to aberrant differentiation and eventual cell death. Although both GBM stem-like cell lines showed high percentage of CD133-positive cells (20% in GSC11 and 70% in GSC23), exposure to serum only caused a moderate decrease of CD133 expression at later time points. Several methods were used to further test the role of ROS in affecting the stemness of the GSC cells and their self-renewal capacity. Addition of 5% FBS or removal of the antioxidant supplements (B27) from the culture medium caused the spheroid GSC cells to attach to the culture surface, exhibit differentiation morphology, decrease expression of certain stem-cell markers, and eventually die within two weeks. Serum exposure also resulted in a decrease of the GSC ability to form colonies in soft agar assay and to grow tumors in a mouse xenograft model. Although an increase of general cellular ROS could be detected when GSC cells were exposed to FBS, the mitochondrial superoxide appeared to be prominent and likely to be a primary event, which led to a compensatory increase of the mitochondrial SOD2 expression and upregulation of glutathione synthesis. Interestingly, addition of the antioxidant N-Acetylcysteine to the FBS-containing medium partially blocked the FBS-induced aberrant differentiation and improved cell viability and self-renewal capacity, suggesting that ROS may play an important role in affecting stemness and differentiation status of the cancer stem cells. We postulate that during tumor development, only the progeny cells that acquire the ability to counteract the impact of ROS increase induced by serum may eventually proliferate and grow as the tumor bulk, and that proper redox-modulation may be a potential novel strategy to block tumor formation and possibly kill the stem-like cancer cells. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4266.

The toxic effects, GSH depletion and radiosensitivity by BSO on retinoblastoma

Depletion of Glutathione by Buthionine Sulfoximine Is Cytotoxic for Human Neuroblastoma Cell Lines via Apoptosis

Effect Of Antisense Oligodeoxynucleotides Glucose Transporter-1 On Enhancement Of Radiosensitivity Of Laryngeal Carcinoma

The Effect of BSO on GSH Content and Chemosensitization of Glioma Cells

Study on in Vitro Reversing Multidrug Resistance of Human Breast Cancer Cells by Buthionine Sulfoximine

A study on the toxicity of three radiosensitizers on retinoblastoma cells by MTT assay

Combined use of sodium borocaptate and buthionine sulfoximine in boron neutron capture therapy enhanced tissue boron uptake and delayed tumor growth in a rat subcutaneous tumor model

S-Adenosylmethionine Inhibits the Proliferation of Retinoblastoma Cell Y79, Induces Apoptosis and Cell Cycle Arrest of Y79 Cells by Inhibiting the Wnt2/β-Catenin Pathway

Adaptive response to GSH depletion and resistance to l-buthionine-(S,R)-sulfoximine: involvement of Nrf2 activation

THE PRELIMINARY STUDY OF THE RELATIONSHIP BETWEEN GLUTATHIONE CONTENT IN HUMAN SGC7901 CELL LINE PRETREATED WITH RADIOSENSITIZER AND ITS SUFFERED RADIATION DOSE

Regulation of the radiosensitivity of tumor cells through HIF-1 alpha dependent intracellular redox status after fractionated radiation

Abstract 4266: Potential role of reactive oxygen species in affecting tumorigenicity of glioblastoma stem cells

Potentiation of Benzo[a]pyrene-Induced Pulmonary and Forestomach Tumorigenesis in Mice by D,L-buthionine-S,R-sulfoximine-mediated Tissue Glutathione Depletion.

BSO up-regulating cisplatin sensitivity of a MRP-overexpression lung cell line SPC-A-1 by changing the activity of GSH detoxification system

CTSB Nuclear Translocation Facilitates DNA Damage and Lysosomal Stress to Promote Retinoblastoma Cell Death

Increased Reactive Oxygen Species and Distinct Oxidative Damage in Resveratrol-suppressed Glioblastoma Cells

Angi-12. The Impact Of Standard-Of-Care Treatment On The Relationship Between Cell Density And Sox2 Positivity In Glioblastoma Patients At Autopsy

Inhibition of glutathione synthesis of Ascaris suum by buthionine sulfoximine

Radiosensitivity of a Monoclonal Human Lung Adenocarcinoma Cell Line with MDR Phenotype Induced by CDDP: an in Vitro Study

Investigation of the effects of a sulfite molecule on human neuroblastoma cells via a novel oncogene URG4/URGCP

Hypertoxic self-assembled peptide with dual functions of glutathione depletion and biosynthesis inhibition for selective tumor ferroptosis and pyroptosis